| 1 |
Wu C, Chen X, Cai Y, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China[J]. JAMA Intern Med, 2020, 180 (7): 934-943.
|
| 2 |
Meyer NJ, Gattinoni L, Calfee CS. Acute respiratory distress syndrome[J]. Lancet, 2021, 398 (10300): 622-637.
|
| 3 |
Wadowski PP, Jilma B, Kopp CW, et al. Glycocalyx as possible limiting factor in COVID-19[J]. Front Immunol, 2021 (12): 607306.
|
| 4 |
Moore KH, Murphy HA, George EM. The glycocalyx: a central regulator of vascular function[J]. Am J Physiol Regul Integr Comp Physiol, 2021, 320 (4): R508-R518.
|
| 5 |
Hu Z, Cano I, D'Amore PA. Update on the role of the endothelial glycocalyx in angiogenesis and vascular inflammation[J]. Front Cell Dev Biol, 2021 (9): 734276.
|
| 6 |
Potje SR, Paula TD, Paulo M, et al. The role of glycocalyx and caveolae in vascular homeostasis and diseases[J]. Front Physiol, 2020 (11): 620840.
|
| 7 |
McDonald KK, Cooper S, Danielzak L, et al. Glycocalyx degradation induces a proinflammatory phenotype and increased leukocyte adhesion in cultured endothelial cells under flow[J]. PLoS One, 2016, 11 (12): e0167576.
|
| 8 |
Zeng Y, Zhang XF, Fu BM, et al. The role of endothelial surface glycocalyx in mechanosensing and transduction[J]. Adv Exp Med Biol, 2018 (1097): 1-27.
|
| 9 |
Ghose S, Biswas S, Datta K, et al. Dynamic hyaluronan drives liver endothelial cells towards angiogenesis[J]. BMC Cancer, 2018, 18 (1): 648.
|
| 10 |
Inagawa R, Okada H, Takemura G, et al. Ultrastructural alteration of pulmonary capillary endothelial glycocalyx during endotoxemia[J]. Chest, 2018, 154 (2): 317-325.
|
| 11 |
Vassiliou AG, Kotanidou A, Dimopoulou I, et al. Endothelial damage in acute respiratory distress syndrome[J]. Int J Mol Sci, 2020, 21 (22): 8793.
|
| 12 |
Dolmatova EV, Wang K, Mandavilli R, et al. The effects of sepsis on endothelium and clinical implications[J]. Cardiovasc Res, 2021, 117 (1): 60-73.
|
| 13 |
宗立永，刘爱敏，丁士芳，等.血管外肺水含量变化与急性呼吸窘迫综合征患者预后的临床研究[J/CD].中华危重症医学杂志（电子版），2021，14（5）：380-385.
|
| 14 |
Schmidt EP, Yang Y, Janssen WJ, et al. The pulmonary endothelial glycocalyx regulates neutrophil adhesion and lung injury during experimental sepsis[J]. Nat Med, 2012, 18 (8): 1217-1223.
|
| 15 |
Jedlicka J, Becker BF, Chappell D. Endothelial glycocalyx[J]. Crit Care Clin, 2020, 36 (2): 217-232.
|
| 16 |
Bellani G, Laffey JG, Pham T, et al. Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries[J]. JAMA, 2016, 315 (8): 788-800.
|
| 17 |
姜黎珊，姚明，杨茂宪，等.不同方式下气管内滴注脂多糖方法制作急性呼吸窘迫综合征大鼠模型[J/CD].中华危重症医学杂志（电子版），2019，12（2）：80-84.
|
| 18 |
Kajita Y, Terashima T, Mori H, et al. A longitudinal change of syndecan-1 predicts risk of acute respiratory distress syndrome and cumulative fluid balance in patients with septic shock: a preliminary study[J]. J Intensive Care, 2021, 9 (1): 27.
|
| 19 |
Murphy LS, Wickersham N, McNeil JB, et al. Endothelial glycocalyx degradation is more severe in patients with non-pulmonary sepsis compared to pulmonary sepsis and associates with risk of ARDS and other organ dysfunction[J]. Ann Intensive Care, 2017, 7 (1): 102.
|
| 20 |
Schonemann-Lund M, Itenov TS, Larsson JE, et al. Endotheliopathy is associated with slower liberation from mechanical ventilation: a cohort study[J]. Crit Care, 2022, 26 (1): 33.
|
| 21 |
Rizzo AN, Haeger SM, Oshima K, et al. Alveolar epithelial glycocalyx degradation mediates surfactant dysfunction and contributes to acute respiratory distress syndrome[J]. JCI Insight, 2022, 7 (2): e154573.
|
| 22 |
Schmidt EP, Overdier KH, Sun X, et al. Urinary glycosaminoglycans predict outcomes in septic shock and acute respiratory distress syndrome[J]. Am J Respir Crit Care Med, 2016, 194 (4): 439-449.
|
| 23 |
Benatti MN, Fabro AT, Miranda CH. Endothelial glycocalyx shedding in the acute respiratory distress syndrome after flu syndrome[J]. J Intensive Care, 2020 (8): 72.
|
| 24 |
Clausen TM, Sandoval DR, Spliid CB, et al. SARS-CoV-2 infection depends on cellular heparan sulfate and ACE2[J]. Cell, 2020, 183 (4): 1043-1057.e1015.
|
| 25 |
Stahl K, Gronski PA, Kiyan Y, et al. Injury to the endothelial glycocalyx in critically ill patients with COVID-19[J]. Am J Respir Crit Care Med, 2020, 202 (8): 1178-1181.
|
| 26 |
Libby P, Luscher T. COVID-19 is, in the end, an endothelial disease[J]. Eur Heart J, 2020, 41 (32): 3038-3044.
|
| 27 |
Fraser DD, Patterson EK, Slessarev M, et al. Endothelial injury and glycocalyx degradation in critically ill coronavirus disease 2019 patients: implications for microvascular platelet aggregation[J]. Crit Care Explor, 2020, 2 (9): e0194.
|
| 28 |
Lambadiari V, Mitrakou A, Kountouri A, et al. Association of COVID-19 with impaired endothelial glycocalyx, vascular function and myocardial deformation 4 months after infection[J]. Eur J Heart Fail, 2021, 23 (11): 1916-1926.
|
| 29 |
Buijsers B, Yanginlar C, de Nooijer A, et al. Increased plasma heparanase activity in COVID-19 patients[J]. Front Immunol, 2020 (11): 575047.
|
| 30 |
Yamaoka-Tojo M. Vascular endothelial glycocalyx damage in COVID-19[J]. Int J Mol Sci, 2020, 21 (24): 9712.
|
| 31 |
Ackermann M, Verleden SE, Kuehnel M, et al. Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19[J]. N Engl J Med, 2020, 383 (2): 120-128.
|
| 32 |
Rovas A, Osiaevi I, Buscher K, et al. Microvascular dysfunction in COVID-19: the MYSTIC study[J]. Angiogenesis, 2021, 24 (1): 145-157.
|
| 33 |
Kozar RA, Pati S. Syndecan-1 restitution by plasma after hemorrhagic shock[J]. J Trauma Acute Care Surg, 2015, 78 (6 Suppl 1): S83-S86.
|
| 34 |
Aldecoa C, Llau JV, Nuvials X, et al. Role of albumin in the preservation of endothelial glycocalyx integrity and the microcirculation: a review[J]. Ann Intensive Care, 2020, 10 (1): 85.
|
| 35 |
Li T, Liu X, Zhao Z, et al. Sulodexide recovers endothelial function through reconstructing glycocalyx in the balloon-injury rat carotid artery model[J]. Oncotarget, 2017, 8 (53): 91350-91361.
|
| 36 |
Mansilha A, Sousa J. Pathophysiological mechanisms of chronic venous disease and implications for venoactive drug therapy[J]. Int J Mol Sci, 2018, 19 (6): 1669.
|
| 37 |
Yu WQ, Zhang SY, Fu SQ, et al. Dexamethasone protects the glycocalyx on the kidney microvascular endothelium during severe acute pancreatitis[J]. J Zhejiang Univ Sci B, 2019, 20 (4): 355-362.
|
| 38 |
Kim WY, Kweon OJ, Cha MJ, et al. Dexamethasone may improve severe COVID-19 via ameliorating endothelial injury and inflammation: a preliminary pilot study[J]. PLoS One, 2021, 16 (7): e0254167.
|
| 39 |
Suzuki K, Okada H, Takemura G, et al. Recombinant thrombomodulin protects against LPS-induced acute respiratory distress syndrome via preservation of pulmonary endothelial glycocalyx[J]. Br J Pharmacol, 2020, 177 (17): 4021-4033.
|
| 40 |
Okamoto H, Muraki I, Okada H, et al. Recombinant antithrombin attenuates acute respiratory distress syndrome in experimental endotoxemia[J]. Am J Pathol, 2021, 191 (9): 1526-1536.
|
| 41 |
Huang L, Zhang X, Ma X, et al. Berberine alleviates endothelial glycocalyx degradation and promotes glycocalyx restoration in LPS-induced ARDS[J]. Int Immunopharmacol, 2018 (65): 96-107.
|
| 42 |
Zhang D, Qi BY, Zhu WW, et al. Crocin alleviates lipopolysaccharide-induced acute respiratory distress syndrome by protecting against glycocalyx damage and suppressing inflammatory signaling pathways[J]. Inflamm Res, 2020, 69 (3): 267-278.
|
| 43 |
Cooper S, Teoh H, Campeau MA, et al. Empagliflozin restores the integrity of the endothelial glycocalyx in vitro[J]. Mol Cell Biochem, 2019, 459 (1-2): 121-130.
|
| 44 |
Potje SR, Costa TJ, Fraga-Silva TFC, et al. Heparin prevents in vitro glycocalyx shedding induced by plasma from COVID-19 patients[J]. Life Sci, 2021 (276): 119376.
|
| 45 |
Lipowsky HH, Lescanic A. Inhibition of inflammation induced shedding of the endothelial glycocalyx with low molecular weight heparin[J]. Microvasc Res, 2017 (112): 72-78.
|
| 46 |
Abassi Z, Hamoud S, Hassan A, et al. Involvement of heparanase in the pathogenesis of acute kidney injury: nephroprotective effect of PG545[J]. Oncotarget, 2017, 8 (21): 34191-34204.
|
| 47 |
Ramnath RD, Butler MJ, Newman G, et al. Blocking matrix metalloproteinase-mediated syndecan-4 shedding restores the endothelial glycocalyx and glomerular filtration barrier function in early diabetic kidney disease[J]. Kidney Int, 2020, 97 (5): 951-965.
|
| 48 |
Zeng Y, Adamson RH, Curry FR, et al. Sphingosine-1-phosphate protects endothelial glycocalyx by inhibiting syndecan-1 shedding[J]. Am J Physiol Heart Circ Physiol, 2014, 306 (3): H363-H372.
|
| 49 |
Hsia K, Yang MJ, Chen WM, et al. Sphingosine-1-phosphate improves endothelialization with reduction of thrombosis in recellularized human umbilical vein graft by inhibiting syndecan-1 shedding in vitro[J]. Acta Biomater, 2017 (51): 341-350.
|
| 50 |
Alves NG, Trujillo AN, Breslin JW, et al. Sphingosine-1-phosphate reduces hemorrhagic shock and resuscitation-induced microvascular leakage by protecting endothelial mitochondrial integrity[J]. Shock, 2019, 52 (4): 423-433.
|
| 51 |
Weinbaum S, Cancel LM, Fu BM, et al. The glycocalyx and its role in vascular physiology and vascular related diseases[J]. Cardiovasc Eng Technol, 2021, 12 (1): 37-71.
|